home / stock / attbf / attbf quote
Last: | $1e-06 |
---|---|
Change Percent: | 0.0% |
Open: | $1e-06 |
Close: | $1e-06 |
High: | $1e-06 |
Low: | $1e-06 |
Volume: | 2,033 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 2,033 | 05-02-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 2,500 | 04-25-2024 |
$0.0001 | $0.0001 | $0.0001 | $0.0001 | $0.0001 | 700 | 04-24-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 25,300 | 04-19-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 32,500 | 04-17-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 26,000 | 04-16-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 1,750 | 04-15-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 408 | 04-10-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 500 | 04-09-2024 |
$1e-06 | $0.0001 | $1e-06 | $0.0001 | $1e-06 | 8,600 | 04-05-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 525 | 04-04-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 1,800 | 04-01-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 100,000 | 03-28-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 500 | 03-22-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 9,300 | 03-21-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 79,100 | 03-13-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 600 | 03-12-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 25,553 | 03-11-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 17,000 | 03-07-2024 |
$1e-06 | $1e-06 | $1e-06 | $1e-06 | $1e-06 | 6,001 | 03-06-2024 |
News, Short Squeeze, Breakout and More Instantly...
Abattis Bioceuticals Corp Company Name:
ATTBF Stock Symbol:
OTCMKTS Market:
After Over Two Years of Legal and Regulatory Battles, Abattis & its Management Receive Vindication VANCOUVER, British Columbia, March 19, 2021 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (“ Abattis ” or the “ Company ”) (OTC: AT...
VANCOUVER, British Columbia, Nov. 08, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp. (the “ Company ” or “ Abattis “) (CSE:ATT) (OTC:ATTBF) announces the following updates on recent developments related to Abattis since the trading of the Company ...
VANCOUVER, British Columbia, Aug. 09, 2019 (GLOBE NEWSWIRE) -- Abattis Bioceuticals Corp (the “ Company ” or “ Abattis ”) (CSE:ATT) (OTC:ATTBF) announces the filing of its annual financial statements for the year ended September 30, 2018 and is pleased to provide...